Lovenox Injection
Product Images NDC 0075-0621

Product Visual Gallery

This gallery contains 32 technical images submitted to the FDA as part of the official labeling for Lovenox (NDC 0075-0621). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sanofi-aventis U.s. Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure A (Lovenox 01)

An instructional diagram showing hands holding a syringe and a vial or container. The image depicts the action of connecting or removing the syringe from the vial, indicated by a double-headed arrow pointing left and right between the syringe and container.*

FDA Label Image

Figure B (Lovenox 02)

An instructional illustration showing a hand holding a prefilled syringe with a blue arrow indicating the direction to inject the content into the lower abdomen, just above the hip. This demonstrates the subcutaneous injection technique for Lovenox, an anticoagulant. The image focuses on proper administration to the abdominal area.*

FDA Label Image

Figure C (Lovenox 03)

An instructional illustration showing a hand holding a prefilled syringe and pointing a blue arrow away from the needle tip, demonstrating the technique for preparing or administering an injection. No text or specific product labeling is visible.*

FDA Label Image

Figure D (Lovenox 04)

An instructional illustration showing a hand holding a prefilled syringe, with a blue arrow indicating the direction to push the plunger. No other text or details are visible.*

FDA Label Image

Figure E (Lovenox 05)

Illustration showing a hand depositing a syringe into a yellow biohazard sharps disposal container labeled with a red biohazard symbol. The image indicates proper disposal of medical sharps to prevent injury or contamination.*

FDA Label Image

Chemical Structure (Lovenox 06)

Chemical structure diagram showing the molecular composition of the active ingredient in Lovenox, an anticoagulant product by sanofi-aventis U.S. LLC. The structure depicts a complex polysaccharide with repeating units, indicating its nature as a low molecular weight heparin.*

FDA Label Image

Chemical Structure (Lovenox 07)

Chemical structure diagram of the active ingredient in Lovenox, showing a complex polysaccharide molecule with sodium salt groups and multiple functional groups represented.*

FDA Label Image

Figure 1 (Lovenox 08)

A forest plot showing relative risk comparisons between unfractionated heparin (UFH) and enoxaparin (Enox) across various patient subgroups. The graph displays the number of patients per subgroup, relative risk values with confidence intervals, and percentage reductions in risk for Enox versus UFH. Subgroups include sex, age, infarct location, diabetes status, prior myocardial infarction, fibrinolytic agent type, time to treatment, and PCI status.*

FDA Label Image

Figure 2 (Lovenox 09)

A Kaplan-Meier curve showing hazard distribution function over time (days) for death or myocardial re-infarction comparing Enoxaparin and UFH (unfractionated heparin). The graph includes a log-rank test p-value and a smaller inset zoomed in to 1 year. Numbers at risk for Enoxaparin and UFH are listed below the x-axis. The chart illustrates cumulative hazard differences between Enoxaparin and UFH over 30 days and 1 year.*

FDA Label Image

Principal Display Panel (30 mg/0.3 mL Syringe Carton)

Illustration showing a Lovenox prefilled syringe with labeled parts before and after use. Before use, the syringe shows the plunger rod, needle, and needle cap. After use, the syringe displays the plunger rod and a protective sleeve covering the needle to enhance safety during disposal.*

FDA Label Image

Principal Display Panel (40 mg/0.4 mL Syringe Carton)

An instructional illustration showing the components included with Lovenox prefilled syringes. It depicts a sharps disposal container, a cotton ball or gauze, an alcohol wipe, a small adhesive bandage, and the Lovenox prefilled syringe itself.*

FDA Label Image

Principal Display Panel (60 mg/0.6 mL Syringe Carton)

An instructional illustration showing two hands handling a prefilled syringe device, one hand peeling back a protective cover while the other holds the syringe steady in preparation for use.*

FDA Label Image

Principal Display Panel (80 mg/0.8 mL Syringe Carton)

Lovenox prefilled syringe with a black needle cap and a white barrel. The syringe includes a plunger and a safety shield. An expiration date field is visible on the barrel near the needle end. The labeler is sanofi-aventis U.S. LLC. Strength is not specified on the syringe label in the image.*

FDA Label Image

Principal Display Panel (100 mg/1 mL Syringe Carton)

An illustration of a syringe partially filled with a clear liquid, showing the plunger and needle. The clear liquid inside the syringe is labeled. This diagram likely demonstrates the appearance or preparation of a liquid medication in a syringe.*

FDA Label Image

Principal Display Panel (300 mg/3 mL Vial Carton)

An instructional illustration showing the abdominal area with two shaded rectangular sites on the left and right sides, indicating possible injection locations for Lovenox administration.*

FDA Label Image

Principal Display Panel (120 mg/0.8 mL Syringe Carton)

An instructional illustration showing a hand holding a small card or pad and wiping or pressing it against the skin on the abdomen near the waistline. The image suggests preparation or cleaning of the injection site, commonly associated with subcutaneous administration guidance.*

FDA Label Image

Principal Display Panel (150 mg/1 mL Syringe Carton)

An instructional illustration showing two hands, one holding a syringe with liquid inside and the other holding a protective cap, demonstrating the removal of the syringe needle cap by pulling it straight off.*

FDA Label Image

Lovenox 18

An instructional illustration demonstrating how to set the dose on a syringe for Lovenox. It shows a hand holding the syringe with an arrow indicating downward movement, alongside the instruction 'Set your dose.'*

FDA Label Image

Lovenox 19

An instructional illustration showing a hand pulling up the waistband of pants or a skirt, likely demonstrating how to prepare the injection site for Lovenox administration.*

FDA Label Image

Lovenox 20

An instructional diagram depicting the proper technique for subcutaneous injection at a 90-degree angle. The image shows a hand holding a syringe and injecting into the abdominal area, with an arrow indicating the direction of injection.*

FDA Label Image

Lovenox 21

An instructional illustration showing a hand administering an injection. The drawing depicts a syringe held close to the skin, with an arrow indicating the direction of injection, possibly for subcutaneous use. No specific product labeling is visible.*

FDA Label Image

Lovenox 22

Instructional illustration showing a hand administering a subcutaneous injection with a syringe into the abdominal area. A second hand is shown pulling the abdominal skin taut away from the injection site to facilitate the injection.*

FDA Label Image

Lovenox 23

An instructional illustration showing a hand holding a syringe with a protective sleeve. An arrow and the word "CLICK" indicate an action to be performed on the syringe, likely related to preparing the injection device.*

FDA Label Image

Lovenox 24

An instructional illustration showing a hand holding a Lovenox syringe about to be disposed of into a Sharps Disposal Container. The syringe is labeled, and the needle cap is visible as part of the disposal process.*

FDA Label Image

Lovenox 25

Lovenox 30 mg/0.3 mL (enoxaparin sodium injection) carton label by sanofi-aventis U.S. LLC. Contains ten single-dose syringes with automatic safety device for subcutaneous injection. Includes manufacturer details, storage instructions, and directions for use with illustrations on proper syringe handling and activation of the safety system.*

FDA Label Image

Lovenox 26

Packaging label for Lovenox 40 mg/0.4 mL (enoxaparin sodium injection) by sanofi-aventis U.S. LLC. This package contains ten single-dose syringes with an automatic safety device for subcutaneous injection. The label includes dosage and administration directions, storage instructions, barcode, and the manufacturer's address in Bridgewater, NJ.*

FDA Label Image

Lovenox 27

Lovenox 60 mg/0.6 mL (enoxaparin sodium injection) single-dose syringes with automatic safety device for subcutaneous injection. Box contains ten 0.6 mL syringes. Labeler is sanofi-aventis U.S. LLC, Bridgewater, NJ. The packaging includes dosage instructions and safety warnings, printed in blue and orange on a white and orange background.*

FDA Label Image

Lovenox 28

Lovenox 80 mg/0.8 mL single dose syringes packaging label for enoxaparin sodium injection by sanofi-aventis U.S. LLC. The carton contains ten 0.8 mL syringes with automatic safety device for subcutaneous injection. The label includes product name, strength, manufacturer, dosage form, quantity, barcode, and a note indicating Rx only status.*

FDA Label Image

Lovenox 29

Lovenox 100 mg/1 mL (enoxaparin sodium injection) box label for ten 1 mL single-dose syringes with automatic safety device, intended for subcutaneous injection. The label includes dosage information, storage instructions, and manufacturer details for sanofi-aventis U.S. LLC.*

FDA Label Image

Lovenox 30

Packaging label for Lovenox 300 mg/3 mL (100 mg/mL) enoxaparin sodium injection by sanofi-aventis U.S. LLC. The label indicates a multiple dose vial for subcutaneous or intravenous injection, including storage instructions, dosage and administration notes, a barcode, and manufacturer information. The label highlights that each 0.1 mL contains 10 mg enoxaparin sodium.*

FDA Label Image

Lovenox 31

Packaging label for Lovenox (enoxaparin sodium injection) 120 mg/0.8 mL single-dose syringes with automatic safety device, for subcutaneous injection. The carton contains ten 0.8 mL syringes. The labeler is sanofi-aventis U.S. LLC. The label includes dosing and administration instructions and a barcode.*

FDA Label Image

Lovenox 32

Lovenox 150 mg/mL (enoxaparin sodium injection) packaging label for single-dose syringes with automatic safety device intended for subcutaneous injection. The box contains ten 1 mL syringes. Labeler is sanofi-aventis U.S. LLC. The label includes dosage instructions, warnings, storage conditions, and manufacturer information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.